Register entry
- Registered sites
- 0
- Active NDC listings
- 2
- Live patents
- 2
- Exclusivities
- 2
- Countries
- 0
Catalogue
Drug listings by form and route
22 active NDC listings: 2 human prescription drug. By marketing category: NDA 2.
| Dosage form | NDCs |
|---|---|
| granule | 1 |
| tablet, film coated | 1 |
| Route | NDCs |
|---|---|
| oral | 2 |
| Labeller name on the listing | NDCs |
|---|---|
| akarx, inc. | 2 |
Exclusivity
Patents and exclusivities
2| Patent | Product | Covers | Expiry |
|---|---|---|---|
| 7638536 | DOPTELET, DOPTELET SPRINKLEavatrombopag maleate | substance, product | Jul 2027 |
| Product | Exclusivity | Until |
|---|---|---|
| DOPTELETAVATROMBOPAG MALEATE | ODE-548 Orphan drug | Jul 2032 |
| DOPTELET SPRINKLEAVATROMBOPAG MALEATE | ODE-548 Orphan drug | Jul 2032 |
Catalogue
Marketed products
2| Brand | Generic name | Form / route | NDC |
|---|---|---|---|
| DOPTELET | avatrombopag maleate | tablet, film coated, oral | 71369-020NDA |
| Doptelet Sprinkle | avatrombopag | granule, oral | 71369-010NDA |
Enquiry
Common questions
- Is AkaRx, Inc. FDA approved?
- AkaRx, Inc. holds no registered establishment of its own; 2 drug products are listed under its name in the National Drug Code Directory, made at sites registered to other firms.
- What drugs does AkaRx, Inc. make?
- 2 products are listed under AkaRx, Inc. in the openFDA NDC Directory, most often as granule; tablet, film coated. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.